SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$14.67
-0.24 (-1.61%)
▼
5d:
+0.82%
30d:
-14.06%
90d:
-33.9%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SNWV shows positive signals but monitor for confirmation. Market pricing in 11.0% growth. Moderate conviction.
💡 BUY OPPORTUNITY: SNWV shows positive signals but monitor for confirmation. Market pricing in 11.0% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $14.67, which is considered oversold relative to its 30-day fair value range of $14.89 to $17.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 39.6) compared to its historical average (29.0). At these levels, the market is pricing in 11.0% annual earnings growth.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNWV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $40.00 (+172.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNWV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $40.00 (+172.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.89 -
$17.00
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 172.7% below Wall St target ($40.00)
- BULLISH: Expecting earnings turnaround to 11.0% growth with 3.1% revenue growth
Trading Range Analysis
30-Day Trading Range
$14.89 -
$17.00
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$14.52
Resistance Level
$17.07
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
39.65
Wall Street Target
$40.00
(+172.7%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
37.2%
Valuation Premium vs History
+11.0% premium
PE vs Historical
39.7 vs 29.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.0%
(market-implied from PE analysis)
1-Year Target
$16.28
(+11%)
2-Year Target
$18.07
(+23%)
3-Year Target
$20.06
(+37%)
3-Yr Target (if PE normalizes)
(PE: 40→29)
PE COMPRESSION
$14.67
(0%)
Earnings growth offset by PE compression
📈
Valuation based on Current Earnings
Trailing PE: 15.53 | Current EPS (TTM): $0.96
Bull Case
$8.20
(-44%)
Analyst growth -50.0%, PE expands to 17.1
Base Case
$7.46
(-49%)
Market implied -50.0%, PE stable at 15.5
Bear Case
$10.14
(-31%)
Severe decline -20.0%, PE contracts to 13.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 16, 2026 1:02 AM ET
Data refreshes hourly during market hours. Next update: 2:02 AM
Data refreshes hourly during market hours. Next update: 2:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 63 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 60 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 53 HOLD |
